News (103)

Sonova : Jahresergebnis 2023/24 PU
Sonova : Präsentation FY 2023/24 (nur Englisch) PU
Financial year 2023/24: Sonova ends year on improving trajectory after growth picks up in second half EQ
Sonova announces Management Board succession EQ
Transcript : Sonova Holding AG, H1 2024 Earnings Call, Nov 21, 2023
First half results 2023/24: Substantial acceleration in sales growth expected as temporary headwinds subside EQ
Sonova : EUHA 2023 Investor Presentation PU
Sonova : EUHA 2023 Investorenpräsentation PU
Sonova further extends offering of Sennheiser-branded   hearing solutions with All-Day Clear EQ
Transcript : Sonova Holding AG, 2023 Earnings Call, May 16, 2023
Sonova : ESG Bericht (nur Englisch) PU
Financial year 2022/23: Sonova delivers solid results  and preserves profit growth EQ
Katya Kruglova to join Sonova’s Management Board as GVP Human Resources & Communications EQ
Sonova launches Conversation Clear Plus earbuds, expanding into the new category of early entry hearing solutions EQ
Sonova completes acquisition of the HYSOUND Group, expanding direct consumer access in China EQ
Transcript : Sonova Holding AG, H1 2023 Earnings Call, Nov 14, 2022
Sonova : Präsentation HY 2022/23 (nur Englisch) PU
Sonova : Presentation HY 2022/23 PU
First half results 2022/23:  Growth in all regions and further progress on strategic initiatives EQ
Transcript : Sonova Holding AG - Analyst/Investor Day
Sonova Investor & Analyst Day 2022: Leading innovation and further expanding our reach EQ
Sonova Investor & Analyst Day 2022: Leading innovation and further expanding our reach EQ
Sonova to enable fully immersive conversations in virtually any situation with new Lumity platform EQ
Sonova to accelerate expansion of direct consumer access in Chinese market with acquisition of leading network of clinics EQ
Transcript : Sonova Holding AG, 2023 Guidance/Update Call, Aug 16, 2022
Sonova revises FY 2022/23 outlook due to subdued market  and ongoing input cost challenge EQ
Transcript : Sonova Holding AG, 2022 Earnings Call, May 17, 2022
Hearing aid maker Sonova beats sales target on pent-up demand RE
Financial year 2021/22: Sonova delivers solid results and significantly advances its growth strategy EQ
Sonova completes acquisition of the Sennheiser Consumer Division and forms a new business EQ
Sonova to increase presence in US market: Acquisition of leading audiological care network EQ
Transcript : Sonova Holding AG, H1 2022 Earnings Call, Nov 15, 2021
Sonova beats half-year earnings estimates, warns of supply chain issues RE
First half results 2021/22: Sustained positive growth momentum and further progress on profitability EQ
Sensorion : And Hearing Care Leader Sonova Sign Strategic Research Collaboration BU
Transcript : Sonova Holding AG - Analyst/Investor Day
Sonova Investor & Analyst Day 2021: Entering a new phase from a position of strength EQ
Sonova : Virtual Investor & Analyst Day 2021 PU
Transcript : Sonova Holding AG, 2021 Earnings Call, May 18, 2021
Sonova : sees strong 2021 growth due to market recovery, new products RE
Financial year 2020/21: Sonova continues to outpace the market and achieves strong growth in the second half-year TE
Sonova : to buy Sennheiser consumer unit to gain younger clients RE
Transcript : Sennheiser electronic GmbH & Co. KG, Sonova Holding AG - M&A Call
Expanding our offering and entering new growth markets – Sonova to acquire Sennheiser Consumer Division TE
Sonova opens one of Switzerland’s first zero-energy office buildings TE
123NextSee all

Insiders

Arnd Kaldowski
Arnd Kaldowski

Arnd Kaldowski holds the position of Chief Executive Officer for Sonova Holding AG and Chief Executive Officer of Sonova AG (a subsidiary of Sonova Holding AG). Mr. Kaldowski is also on the board of European Hearing Instrument Manufacturing Association. He previously held the position of Vice President & Group Executive at Danaher Corp. President for Beckman Coulter Diagnostics Ltd. President-Diagnostics Division at Beckman Coulter, Inc. and Executive Vice President-Sales & Marketing at Leica Microsystems GmbH (which are all subsidiaries of Danaher Corp.), Investment Director at Atila Venture Partners Ltd. (Swiss branch), Senior Vice President of Siemens Medical Systems, Inc. and Manager at Boston Consulting Group Holding AG. He received a graduate degree from Technische Universität Darmstadt and an MBA from INSEAD.





Picture Arnd Zinnhardt
Arnd Zinnhardt

Arnd Zinnhardt is currently a Director at Software AG (U.K.) Ltd., a Member-Supervisory Board at Dürr AG, a Member-Supervisory Board at Aareon AG, and a Member-Supervisory Board at Grant Thornton AG (Germany) and Warth & Klein Grant Thornton GmbH & Co. KG.
Previously, he was a Director-Supervisory Board at IDS Scheer AG, Chief Financial Officer at Software AG, a Partner at BDO AG Wirtschaftsprüfungsgesellschaft, and a Principal at Ernst & Young LLP (Missouri).
He also served as a Member-Supervisory Board at Landesbank Hessen-Thüringen Girozentrale.
Mr. Zinnhardt received his undergraduate degree from Universität zu Köln.



Picture Arnd Schäfer
Arnd Schäfer

Arnd Schäfer worked as an Economist at Westlb AG from 2000 to 2012 and also worked as an Economist at Portigon AG.




Picture Arnd Christ
Arnd Christ

Arnd Christ is the founder of Cf Port GmbH.
He currently holds the position of Chief Financial Officer at Immatics Biotechnologies GmbH and Immatics NV.
Previously, he served as Finance Director at Avery Dennison Corp., Hoechst AG, and Avery Dennison GmbH.
He also held the role of Chief Financial Officer at MediGene AG, Vivoryon Therapeutics NV, NovImmune SA, Proteros biostructures GmbH, and EleGene AG.
Additionally, he was the Chief Financial Officer at InflaRx NV until 2020.
Mr. Christ has also served as a Member-Supervisory Board at Immunocore Holdings Plc.
He obtained an MBA from Boston University and Wuerzburg Schweinfurt University of Applied Sciences.

No results for this search

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW